Intellectual Property India Publishes Patent Application for 'Compounds For Modulating Hur (ELAVL1)' Filed by Shanghai Degron Biomedical Technology Co. Ltd.

MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517058456 A) filed by Shanghai Degron Biomedical Technology Co. Ltd., Shanghai, on June 18, for 'compounds for modulating hur (elavl1).'

Inventor(s) include Zou, Lihui; Yang, Zheng; Sun, Zhuming; Su, Hexiu; Geng, Chenlu; and Dou, Hao.

The application for the patent was published on July 4, under issue no. 27/2025.

According to the abstract released by the Intellectual Property India: "The application relates to a compound of Formula (I) or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which degrades HuR, a pharmaceutical composition comprising a compound of Formula (I), and a method of treating or preventing a disease in which HuR plays a role."

The patent application was internationally filed on Nov. 28, 2023, under International application No.PCT/CN2023/134754.

Disclaimer: Curated by HT Syndication.